Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company
19:53 EDT 20 Aug 2012 | Xconomy
San Diego’s Regulus Therapeutics plans to raise $57.5 million in an IPO that takes advantage of incentives for emerging growth companies provided under the Jump Start Our Business Startups (JOBS) Act passed earlier this year. In its IPO filing, the..
Original Article: Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company
More From BioPortfolio on "Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
